This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Health Care Stocks On The Rise With Help From 5 Stocks

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 23 points (-0.2%) at 15,311 as of Wednesday, Sept. 25, 2013, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,760 issues advancing vs. 1,167 declining with 109 unchanged.

The Health Care sector currently sits up 0.9% versus the S&P 500, which is up 0.1%. Top gainers within the sector include Merck ( MRK), up 0.7%, and Eli Lilly and Company ( LLY), up 0.8%. On the negative front, top decliners within the sector include Baxter International ( BAX), down 6.3%, Stryker Corporation ( SYK), down 2.3%, Zimmer Holdings ( ZMH), down 1.6%, WellPoint ( WLP), down 1.2% and Novo Nordisk A/S ( NVO), down 0.9%.

TheStreet would like to highlight 5 stocks pushing the sector higher today:

5. MAKO Surgical Corporation ( MAKO) is one of the companies pushing the Health Care sector higher today. As of noon trading, MAKO Surgical Corporation is up $13.32 (82.4%) to $29.49 on heavy volume. Thus far, 35.7 million shares of MAKO Surgical Corporation exchanged hands as compared to its average daily volume of 851,100 shares. The stock has ranged in price between $29.46-$29.59 after having opened the day at $29.49 as compared to the previous trading day's close of $16.17.

MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. MAKO Surgical Corporation has a market cap of $765.6 million and is part of the health services industry. Shares are up 26.7% year to date as of the close of trading on Tuesday. Currently there are 3 analysts that rate MAKO Surgical Corporation a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates MAKO Surgical Corporation as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full MAKO Surgical Corporation Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs